Showing 1 to 3 of 3 results


Chinese Patent Granted for Proteomics' Muscle Stress Test
OxiDx Limited, a 66 percent-owned subsidiary of ASX-listed Proteomics International Laboratories, secured a Chinese patent for its muscle stress test, a rapid, low-cost blood test detecting muscle damage caused by oxidative stress, impacting athletes, racehorses, and general health.
Chinese Patent Granted for Proteomics' Muscle Stress Test
OxiDx Limited, a 66 percent-owned subsidiary of ASX-listed Proteomics International Laboratories, secured a Chinese patent for its muscle stress test, a rapid, low-cost blood test detecting muscle damage caused by oxidative stress, impacting athletes, racehorses, and general health.
Progress
52% Bias Score


OxiDx's New Blood Test Detects Muscle Damage, Revolutionizing Sports Medicine
OxiDx, a Proteomics International subsidiary, unveiled a new fingerprick blood test accurately measuring muscle damage via oxidative stress biomarkers in 20 elite marathon runners, with results published in Physiological Reports, showing potential for personalized recovery and broader medical applic...
OxiDx's New Blood Test Detects Muscle Damage, Revolutionizing Sports Medicine
OxiDx, a Proteomics International subsidiary, unveiled a new fingerprick blood test accurately measuring muscle damage via oxidative stress biomarkers in 20 elite marathon runners, with results published in Physiological Reports, showing potential for personalized recovery and broader medical applic...
Progress
48% Bias Score

OxiDx Secures Patent, Poised for Billion-Dollar Market Entry
Proteomics International's subsidiary OxiDx secured an Australian patent for its finger-prick oxidative muscle stress test, showing promise in detecting muscle damage in athletes and racehorses, with commercial rollout planned for mid-year in Australia and the US soon after.

OxiDx Secures Patent, Poised for Billion-Dollar Market Entry
Proteomics International's subsidiary OxiDx secured an Australian patent for its finger-prick oxidative muscle stress test, showing promise in detecting muscle damage in athletes and racehorses, with commercial rollout planned for mid-year in Australia and the US soon after.
Progress
48% Bias Score
Showing 1 to 3 of 3 results